Estrogen/GPR30 Signaling Contributes to the Malignant Potentials of ER-Negative Cervical Adenocarcinoma via Regulation of Claudin-1 Expression

Cervical adenocarcinomas are believed to lose estrogen response on the basis of no expression of a nuclear estrogen receptor such as ERα in clinical pathology. Here, we demonstrated that cervical adenocarcinoma cells respond to a physiological concentration of estrogen to upregulate claudin-1, a cel...

Full description

Bibliographic Details
Main Authors: Taishi Akimoto, Akira Takasawa, Kumi Takasawa, Tomoyuki Aoyama, Masaki Murata, Makoto Osanai, Tsuyoshi Saito, Norimasa Sawada
Format: Article
Language:English
Published: Elsevier 2018-10-01
Series:Neoplasia: An International Journal for Oncology Research
Online Access:http://www.sciencedirect.com/science/article/pii/S1476558618302744
_version_ 1819194604295028736
author Taishi Akimoto
Akira Takasawa
Kumi Takasawa
Tomoyuki Aoyama
Masaki Murata
Makoto Osanai
Tsuyoshi Saito
Norimasa Sawada
author_facet Taishi Akimoto
Akira Takasawa
Kumi Takasawa
Tomoyuki Aoyama
Masaki Murata
Makoto Osanai
Tsuyoshi Saito
Norimasa Sawada
author_sort Taishi Akimoto
collection DOAJ
description Cervical adenocarcinomas are believed to lose estrogen response on the basis of no expression of a nuclear estrogen receptor such as ERα in clinical pathology. Here, we demonstrated that cervical adenocarcinoma cells respond to a physiological concentration of estrogen to upregulate claudin-1, a cell surface molecule highly expressed in cervical adenocarcinomas. Knockout of claudin-1 induced apoptosis and significantly inhibited proliferation, migration, and invasion of cervical adenocarcinoma cells and tumorigenicity in vivo. Importantly, all of the cervical adenocarcinoma cell lines examined expressed a membrane-bound type estrogen receptor, G protein–coupled receptor 30 (GPR30/GPER1), but not ERα. Estrogen-dependent induction of claudin-1 expression was mediated by GPR30 via ERK and/or Akt signaling. In surgical specimens, there was a positive correlation between claudin-1 expression and GPR30 expression. Double high expression of claudin-1 and GPR30 predicts poor prognosis in patients with cervical adenocarcinomas. Mechanism-based targeting of estrogen/GPR30 signaling and claudin-1 may be effective for cervical adenocarcinoma therapy.
first_indexed 2024-12-23T01:59:30Z
format Article
id doaj.art-1756d9b80c7941218a0274cba9406495
institution Directory Open Access Journal
issn 1476-5586
language English
last_indexed 2024-12-23T01:59:30Z
publishDate 2018-10-01
publisher Elsevier
record_format Article
series Neoplasia: An International Journal for Oncology Research
spelling doaj.art-1756d9b80c7941218a0274cba94064952022-12-21T18:04:02ZengElsevierNeoplasia: An International Journal for Oncology Research1476-55862018-10-01201010831093Estrogen/GPR30 Signaling Contributes to the Malignant Potentials of ER-Negative Cervical Adenocarcinoma via Regulation of Claudin-1 ExpressionTaishi Akimoto0Akira Takasawa1Kumi Takasawa2Tomoyuki Aoyama3Masaki Murata4Makoto Osanai5Tsuyoshi Saito6Norimasa Sawada7Department of Pathology, Sapporo Medical University School of Medicine, Sapporo, Hokkaido, 060-8556, Japan; Department of Obstetrics and Gynecology, Sapporo Medical University School of Medicine, Sapporo, Hokkaido, 060-8556, JapanDepartment of Pathology, Sapporo Medical University School of Medicine, Sapporo, Hokkaido, 060-8556, Japan; Address all correspondence to: Akira Takasawa, Department of Pathology, Sapporo Medical University School of Medicine, S1 W17, Chuo-ku, Sapporo 060-8556, Japan.Department of Pathology, Sapporo Medical University School of Medicine, Sapporo, Hokkaido, 060-8556, JapanDepartment of Pathology, Sapporo Medical University School of Medicine, Sapporo, Hokkaido, 060-8556, JapanDepartment of Pathology, Sapporo Medical University School of Medicine, Sapporo, Hokkaido, 060-8556, JapanDepartment of Pathology, Sapporo Medical University School of Medicine, Sapporo, Hokkaido, 060-8556, JapanDepartment of Obstetrics and Gynecology, Sapporo Medical University School of Medicine, Sapporo, Hokkaido, 060-8556, JapanDepartment of Pathology, Sapporo Medical University School of Medicine, Sapporo, Hokkaido, 060-8556, JapanCervical adenocarcinomas are believed to lose estrogen response on the basis of no expression of a nuclear estrogen receptor such as ERα in clinical pathology. Here, we demonstrated that cervical adenocarcinoma cells respond to a physiological concentration of estrogen to upregulate claudin-1, a cell surface molecule highly expressed in cervical adenocarcinomas. Knockout of claudin-1 induced apoptosis and significantly inhibited proliferation, migration, and invasion of cervical adenocarcinoma cells and tumorigenicity in vivo. Importantly, all of the cervical adenocarcinoma cell lines examined expressed a membrane-bound type estrogen receptor, G protein–coupled receptor 30 (GPR30/GPER1), but not ERα. Estrogen-dependent induction of claudin-1 expression was mediated by GPR30 via ERK and/or Akt signaling. In surgical specimens, there was a positive correlation between claudin-1 expression and GPR30 expression. Double high expression of claudin-1 and GPR30 predicts poor prognosis in patients with cervical adenocarcinomas. Mechanism-based targeting of estrogen/GPR30 signaling and claudin-1 may be effective for cervical adenocarcinoma therapy.http://www.sciencedirect.com/science/article/pii/S1476558618302744
spellingShingle Taishi Akimoto
Akira Takasawa
Kumi Takasawa
Tomoyuki Aoyama
Masaki Murata
Makoto Osanai
Tsuyoshi Saito
Norimasa Sawada
Estrogen/GPR30 Signaling Contributes to the Malignant Potentials of ER-Negative Cervical Adenocarcinoma via Regulation of Claudin-1 Expression
Neoplasia: An International Journal for Oncology Research
title Estrogen/GPR30 Signaling Contributes to the Malignant Potentials of ER-Negative Cervical Adenocarcinoma via Regulation of Claudin-1 Expression
title_full Estrogen/GPR30 Signaling Contributes to the Malignant Potentials of ER-Negative Cervical Adenocarcinoma via Regulation of Claudin-1 Expression
title_fullStr Estrogen/GPR30 Signaling Contributes to the Malignant Potentials of ER-Negative Cervical Adenocarcinoma via Regulation of Claudin-1 Expression
title_full_unstemmed Estrogen/GPR30 Signaling Contributes to the Malignant Potentials of ER-Negative Cervical Adenocarcinoma via Regulation of Claudin-1 Expression
title_short Estrogen/GPR30 Signaling Contributes to the Malignant Potentials of ER-Negative Cervical Adenocarcinoma via Regulation of Claudin-1 Expression
title_sort estrogen gpr30 signaling contributes to the malignant potentials of er negative cervical adenocarcinoma via regulation of claudin 1 expression
url http://www.sciencedirect.com/science/article/pii/S1476558618302744
work_keys_str_mv AT taishiakimoto estrogengpr30signalingcontributestothemalignantpotentialsofernegativecervicaladenocarcinomaviaregulationofclaudin1expression
AT akiratakasawa estrogengpr30signalingcontributestothemalignantpotentialsofernegativecervicaladenocarcinomaviaregulationofclaudin1expression
AT kumitakasawa estrogengpr30signalingcontributestothemalignantpotentialsofernegativecervicaladenocarcinomaviaregulationofclaudin1expression
AT tomoyukiaoyama estrogengpr30signalingcontributestothemalignantpotentialsofernegativecervicaladenocarcinomaviaregulationofclaudin1expression
AT masakimurata estrogengpr30signalingcontributestothemalignantpotentialsofernegativecervicaladenocarcinomaviaregulationofclaudin1expression
AT makotoosanai estrogengpr30signalingcontributestothemalignantpotentialsofernegativecervicaladenocarcinomaviaregulationofclaudin1expression
AT tsuyoshisaito estrogengpr30signalingcontributestothemalignantpotentialsofernegativecervicaladenocarcinomaviaregulationofclaudin1expression
AT norimasasawada estrogengpr30signalingcontributestothemalignantpotentialsofernegativecervicaladenocarcinomaviaregulationofclaudin1expression